Table 2.

Nonmelanoma skin cancer participants’ characteristics.

Histopathology:	BCC (n = 18)	BSC (n = 2)	SCC (n = 18)	p-Value
Age, median (IQR)	70.5 (62–78)	76 (74.5–77.5)	76.5 (65.25–84.5)	0.454
Sex (F), n (%)	10 (55.56)	1 (50)	7 (38.89)	0.747
Breslow, median (IQR)	5.45 (3.67–9.38)	4.1 (3.55–4.65)	7 (5–12)	0.439 {0.659/0.747/0.156}
Clark, n (%)				0.267
II:	1 (5.56)	0 (0)	1 (5.88)
III:	1 (5.56)	0 (0)	0 (0)
IV:	7 (38.89)	1 (50)	2 (11.76)
V:	9 (50)	1 (50)	14 (82.35)
Clark IV/V, n (%)	16 (88.89)	2 (100)	16 (88.89)
T3/4, n (%)	4 (22.22)	0 (0)	12 (66.67)	0.011
V1, n (%)	1 (5.56)	1 (50)	2 (11.11)	0.285
L1, n (%)	1 (5.56)	0 (0)	5 (27.78)	0.239
R1, n (%)	4 (22.22)	1 (50)	3 (16.67)	0.523
Pn1, n (%)	4 (22.22)	0 (0)	8 (44.44)	0.292

T, tumor stage; V, vascular invasion; L, lymphatic invasion, R, resection margin; Pn, perineural invasion; IQR, interquartile range.